The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABCELLERA BIOLOGICS INC | COM | 00288U106 | 2,629,330 | 407,017 | SH | SOLE | 407,017 | 0 | 0 | |||
| AFFIRM HLDGS INC | COM CL A | 00827B106 | 24,870,442 | 1,622,338 | SH | SOLE | 1,622,338 | 0 | 0 | |||
| OPENDOOR TECHNOLOGIES INC | COM | 683712103 | 502,500 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | |||